In lung cancer, a different LMO7‐ALK variant, L15:A20, was reported in molecular analysis of 158 ALK‐rearranged NSCLCs but no treatment information and clinical follow‐ups were available.13 This evidence concerns the gene ALK and lung carcinoma.